# Tumor Characteristics in Patients With Paraneoplastic Neurological Syndromes (PNS)

> **NCT03963700** · — · UNKNOWN · sponsor: **Hospices Civils de Lyon** · enrollment: 980 (estimated)

## Conditions studied

- Cancer
- Paraneoplastic Syndromes
- Neurologic Disorder
- Immune System and Related Disorders
- Tumor Genetics

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03963700
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-02-01
- **Primary completion:** 2022-01-01
- **Final completion:** 2022-01-01
- **Target enrollment:** 980 (ESTIMATED)
- **Last updated:** 2019-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03963700

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03963700, "Tumor Characteristics in Patients With Paraneoplastic Neurological Syndromes (PNS)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03963700. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
